FDA Launches Regulatory Science Initiative with Personalized Rx Focus Areas

FDA has included personalized medicine among several research areas to which it plans to apply "the bulk" of its $25 million FY 2011 budget increase designated for regulatory science initiatives.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.